LFMD LAWSUIT ALERT: Levi & Korsinsky Notifies LifeMD, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline
Levi & Korsinsky is pursuing a class action lawsuit against LifeMD, Inc. for alleged securities fraud between May and August 2025.Summary
Levi & Korsinsky, LLP has announced a class action lawsuit for investors of LifeMD, Inc. (NASDAQ: LFMD) who experienced losses between May 7, 2025, and August 5, 2025. The lawsuit alleges that LifeMD made false and misleading statements regarding its competitive position and financial guidance, specifically overstating its competitive position and failing to account for rising customer acquisition costs related to its RexMD segment and obesity treatment drugs like Wegovy and Zepbound. Investors who suffered losses during this period have until October 27, 2025, to request appointment as lead plaintiff. Participation in the lawsuit does not require serving as lead plaintiff, and there are no out-of-pocket costs for class members. Levi & Korsinsky highlights its successful track record in securities litigation, including ranking among the top firms in the United States by ISS Securities Class Action Services.
(Source：NewMediaWire)